MetaCap

IN8bio Insider Trades

NASDAQ: INABHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.34-0.04 (-2.90%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

IN8bio insider activity

Over the last 12 months, IN8bio insiders reported 7 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows FAIRBAIRN EMILY (Director) reporting a transaction in 724,637 shares on May 27, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INAB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

INAB insider transactions

IN8bio insider transactions
DateInsiderTypeSharesValueFiling
May 27, 2026FAIRBAIRN EMILYDirectorGift724,637—Form 4
Dec 22, 2025FAIRBAIRN EMILYDirectorAward724,637$1000.00KForm 4
Dec 22, 2025Brandt Peter C.DirectorAward72,464$100.00KForm 4
Dec 22, 2025Roemer Alan S.DirectorAward36,232$50.00KForm 4
Dec 22, 2025Ho William Tai-WeiPRESIDENT AND CEOAward36,232$50.00KForm 4
Dec 22, 2025McCall PatrickCHIEF FINANCIAL OFFICERAward7,247$10.00KForm 4
Dec 22, 2025Rochlin KateChief Operating OfficerAward7,247$10.00KForm 4
Apr 30, 2025Roemer Alan S.DirectorOption exercise11,000$2.03KForm 4
Apr 30, 2025Roemer Alan S.DirectorOption exercise102,459$18.89KForm 4
Apr 30, 2025Rochlin KateChief Operating OfficerOption exercise12,295$2.27KForm 4
Apr 30, 2025Brandt Peter C.DirectorOption exercise81,967$15.11KForm 4
Apr 30, 2025Brandt Peter C.DirectorOption exercise81,967$15.11KForm 4
Apr 30, 2025McCall PatrickCHIEF FINANCIAL OFFICEROption exercise15,000$2.77KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related